NCT07100483
Comparing Surgical Management Methods of Atrial Fibrillation
Enrolling by Invitation
NAAges 18–85InterventionalTreatmentCorewell Health WestInvestigator-initiated
~220 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Atrial Fibrillation Ablation
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Freedom from Atrial Fibrillation
Measured over 30 days and 1 year
Conditions
NCT07100483
Where you'd take part
This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.
Corewell Health West
Grand Rapids, Michiganno site contact published
Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.
Study leadership
- Charles Willekes, MD · PRINCIPAL_INVESTIGATOR · Corewell Health
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Want this trial checked against your situation?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Adult patients with a history of preoperative atrial fibrillation, either paroxysmal or persistent, requiring concomitant surgical ablation who are scheduled to undergo cardiac surgical procedure(s) to be performed on cardiopulmonary bypass
Utilizing sternotomy approach requiring cardiopulmonary bypass
Male or Female subjects between age 18 to 85 years of age
Exclusion
LVEF \< 25%
LAVI \> 59ml/m②
Presence of Pacemaker/AICD
History of VT/VF, WPW
Re-operative cardiac surgery
What this trial measures
- Freedom from Atrial Fibrillation30 days and 1 year
Freedom from atrial fibrillation at 30 days and one year